Blood count study for severe chronic neutropenia
Part of Blood & lymphatic clinical trials.
This study tests a way to track your blood counts at home using a finger-stick device and a smartphone app. It may help people with severe chronic neutropenia, a condition with very low white blood cells, manage their care more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with severe chronic neutropenia, a condition where your body has very low levels of infection-fighting white blood cells.
- You must be 5 years old or older.
- You must have a confirmed ELANE gene change (mutation) that is linked to your neutropenia.
- You need a computer or smartphone that can download and install apps, and you must have internet access.
- You (or a caregiver) must be comfortable collecting a small blood sample at home using a finger-stick device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how common a harmless condition called ethnic neutropenia (low white blood cells) and a specific blood type (Duffy null) are in newborns at Kaplan Medical Center. It helps doctors understand normal blood cell differences across ethnic groups.
This study follows adults with autoimmune blood problems like autoimmune hemolytic anemia, immune thrombocytopenia, and autoimmune/neutropenia to see how diagnosis and care work over time. You may be asked to complete follow-up visits for up to 3 years.
This study follows people who may have early, unclear blood count problems or certain genetic/immune patterns that can later lead to bone marrow failure or blood cancers. It may help doctors better understand risks over time and guide earlier care.
This study tests a new blood testing device on healthy adults to see if it works well and is easy to use. It may help improve how blood tests are done in the future.
This study collects a type of blood cell called single nucleated cells from healthy volunteers to see what affects the collection. It may help researchers learn how to improve future treatments.
This study tests whether cancer patients can do their own blood counts at home using a finger-prick test. It will help see if home monitoring is a good option for people receiving chemotherapy.
Hear when a new Neutropenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.